Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
4D pharma announces passing of CFO John Beck » 08:07
07/26/21
07/26
08:07
07/26/21
08:07
LBPS

4D pharma

$9.25 /

+0.15 (+1.65%)

4D pharma announced with…

4D pharma announced with great sadness that John Beck, CFO of 4D pharma, has passed away. 4D pharma will continue to be actively led by its current management team and board of directors and succession planning is underway.

ShowHide Related Items >><<
LBPS 4D pharma
$9.25 /

+0.15 (+1.65%)

LBPS 4D pharma
$9.25 /

+0.15 (+1.65%)

07/09/21 Chardan
4D pharma assumed with a Buy at Chardan
05/13/21
Fly Intel: Top five analyst initiations
05/13/21 Ladenburg
Ladenburg starts 4D pharma with Buy, $35 price target
05/13/21 Ladenburg
4D pharma initiated with a Buy at Ladenburg
LBPS 4D pharma
$9.25 /

+0.15 (+1.65%)

Conference/Events
4D pharma management to meet virtually with Oppenheimer » 04:55
07/23/21
07/23
04:55
07/23/21
04:55
LBPS

4D pharma

$9.08 /

-0.01 (-0.11%)

Virtual Meetings to be…

Virtual Meetings to be held on July 22-23 hosted by Oppenheimer.

ShowHide Related Items >><<
LBPS 4D pharma
$9.08 /

-0.01 (-0.11%)

LBPS 4D pharma
$9.08 /

-0.01 (-0.11%)

07/09/21 Chardan
4D pharma assumed with a Buy at Chardan
05/13/21
Fly Intel: Top five analyst initiations
05/13/21 Ladenburg
Ladenburg starts 4D pharma with Buy, $35 price target
05/13/21 Ladenburg
4D pharma initiated with a Buy at Ladenburg
LBPS 4D pharma
$9.08 /

-0.01 (-0.11%)

Conference/Events
4D pharma management to meet virtually with Oppenheimer » 04:55
07/22/21
07/22
04:55
07/22/21
04:55
LBPS

4D pharma

$9.24 /

+0.19 (+2.10%)

Virtual Meetings to be…

Virtual Meetings to be held on July 22-23 hosted by Oppenheimer.

ShowHide Related Items >><<
LBPS 4D pharma
$9.24 /

+0.19 (+2.10%)

LBPS 4D pharma
$9.24 /

+0.19 (+2.10%)

07/09/21 Chardan
4D pharma assumed with a Buy at Chardan
05/13/21
Fly Intel: Top five analyst initiations
05/13/21 Ladenburg
Ladenburg starts 4D pharma with Buy, $35 price target
05/13/21 Ladenburg
4D pharma initiated with a Buy at Ladenburg
LBPS 4D pharma
$9.24 /

+0.19 (+2.10%)

Conference/Events
4D pharma management to meet virtually with Oppenheimer » 13:05
07/16/21
07/16
13:05
07/16/21
13:05
LBPS

4D pharma

$9.60 /

+ (+0.00%)

Virtual Meetings to be…

Virtual Meetings to be held on July 22-23 hosted by Oppenheimer.

ShowHide Related Items >><<
LBPS 4D pharma
$9.60 /

+ (+0.00%)

LBPS 4D pharma
$9.60 /

+ (+0.00%)

07/09/21 Chardan
4D pharma assumed with a Buy at Chardan
05/13/21
Fly Intel: Top five analyst initiations
05/13/21 Ladenburg
Ladenburg starts 4D pharma with Buy, $35 price target
05/13/21 Ladenburg
4D pharma initiated with a Buy at Ladenburg
LBPS 4D pharma
$9.60 /

+ (+0.00%)

Conference/Events
Ladeburg to hold a virtual conference » 04:55
07/14/21
07/14
04:55
07/14/21
04:55
PHGE

BiomX

$5.75 /

+0.17 (+3.05%)

, AYLA

Ayala Pharmaceuticals

$11.36 /

+0.75 (+7.07%)

, VCEL

Vericel

$53.57 /

-0.35 (-0.65%)

, FSTX

F-star Therapeutics

$7.25 /

-0.56 (-7.17%)

, LBPS

4D pharma

$10.16 /

-0.01 (-0.10%)

, IMUX

Immunic

$12.31 /

-0.5 (-3.90%)

, IMNM

Immunome

$16.07 /

-0.85 (-5.02%)

, SPRO

Spero Therapeutics

$14.38 /

-0.64 (-4.26%)

, SLRX

Salarius Pharmaceuticals

/

+

, ZYNE

Zynerba

$4.91 /

+ (+0.00%)

, TARA

Protara Therapeutics

$8.81 /

-0.23 (-2.54%)

, ITMR

Itamar Medical

$23.04 /

-0.16 (-0.69%)

, CATB

Catabasis Pharmaceuticals

$1.82 /

-0.16 (-8.08%)

, BWAY

Brainsway

$9.50 /

-0.15 (-1.55%)

, BNGO

Bionano Genomics

$6.08 /

-0.43 (-6.61%)

, AXSM

Axsome Therapeutics

$63.37 /

-1.92 (-2.94%)

, ARX

Aeroflex

$10.50 /

+ (+0.00%)

, XCUR

Exicure

$1.48 /

-0.015 (-1.00%)

Healthcare Virtual…

Healthcare Virtual Conference will be held on July 13-14.Webcast Link

ShowHide Related Items >><<
ZYNE Zynerba
$4.91 /

+ (+0.00%)

XCUR Exicure
$1.48 /

-0.015 (-1.00%)

VCEL Vericel
$53.57 /

-0.35 (-0.65%)

TARA Protara Therapeutics
$8.81 /

-0.23 (-2.54%)

SPRO Spero Therapeutics
$14.38 /

-0.64 (-4.26%)

SLRX Salarius Pharmaceuticals
/

+

PHGE BiomX
$5.75 /

+0.17 (+3.05%)

LBPS 4D pharma
$10.16 /

-0.01 (-0.10%)

ITMR Itamar Medical
$23.04 /

-0.16 (-0.69%)

IMUX Immunic
$12.31 /

-0.5 (-3.90%)

IMNM Immunome
$16.07 /

-0.85 (-5.02%)

FSTX F-star Therapeutics
$7.25 /

-0.56 (-7.17%)

CATB Catabasis Pharmaceuticals
$1.82 /

-0.16 (-8.08%)

BWAY Brainsway
$9.50 /

-0.15 (-1.55%)

BNGO Bionano Genomics
$6.08 /

-0.43 (-6.61%)

AYLA Ayala Pharmaceuticals
$11.36 /

+0.75 (+7.07%)

AXSM Axsome Therapeutics
$63.37 /

-1.92 (-2.94%)

PHGE BiomX
$5.75 /

+0.17 (+3.05%)

04/15/21 Ladenburg
Ladenburg starts BiomX with $25 target, says buy ahead of acne data
04/15/21 Ladenburg
BiomX initiated with a Buy at Ladenburg
02/02/21 H.C. Wainwright
BiomX overcame 'significant hurdle' with Phase 1a data, says H.C. Wainwright
12/07/20 H.C. Wainwright
BiomX initiated with a Buy at H.C. Wainwright
AYLA Ayala Pharmaceuticals
$11.36 /

+0.75 (+7.07%)

07/13/21 Ladenburg
Ayala Pharmaceuticals initiated with Buy, $29 target at Ladenburg
07/13/21 Ladenburg
Ayala Pharmaceuticals initiated with a Buy at Ladenburg
12/07/20
Fly Intel: Top five analyst initiations
12/07/20 Roth Capital
Ayala Pharmaceuticals initiated with a Buy at Roth Capital
VCEL Vericel
$53.57 /

-0.35 (-0.65%)

05/06/21 H.C. Wainwright
Vericel price target raised to $65 from $60 at H.C. Wainwright
02/25/21 SVB Leerink
Vericel price target raised to $60 from $50 at SVB Leerink
02/22/21 BTIG
Vericel price target raised to $56 from $45 at BTIG
02/16/21 Truist
Vericel price target raised to $60 from $40 at Truist
FSTX F-star Therapeutics
$7.25 /

-0.56 (-7.17%)

07/08/21 SVB Leerink
F-star Therapeutics initiated with an Outperform at SVB Leerink
06/09/21 B. Riley
B. Riley starts F-star Therapeutics at Buy, sees 307% potential upside
06/08/21 B. Riley
F-star Therapeutics initiated with a Buy at B. Riley
04/15/21 Oppenheimer
Opco starts F-star Therapeutics with Outperform, $30 price target
LBPS 4D pharma
$10.16 /

-0.01 (-0.10%)

07/09/21 Chardan
4D pharma assumed with a Buy at Chardan
05/13/21
Fly Intel: Top five analyst initiations
05/13/21 Ladenburg
Ladenburg starts 4D pharma with Buy, $35 price target
05/13/21 Ladenburg
4D pharma initiated with a Buy at Ladenburg
IMUX Immunic
$12.31 /

-0.5 (-3.90%)

07/13/21 Piper Sandler
Investors 'missing out' on Immunic's IMU-935 opportunity, says Piper Sandler
07/02/21 Roth Capital
Immunic cleared for Phase 3 studies after 'stellar' data, says Roth Capital
07/01/21 Piper Sandler
Piper Sandler 'pleased' with Immunic's IMU-838 IND clearance, studies
05/07/21 JMP Securities
Immunic price target raised to $56 from $55 at JMP Securities
IMNM Immunome
$16.07 /

-0.85 (-5.02%)

10/27/20 Chardan
Immunome initiated with a Buy at Chardan
10/26/20 Ladenburg
Immunome initiated with a Buy at Ladenburg
SPRO Spero Therapeutics
$14.38 /

-0.64 (-4.26%)

01/22/21 H.C. Wainwright
Spero Therapeutics price target raised to $40 from $33 at H.C. Wainwright
12/16/20 Berenberg
Berenberg starts 'greatly underappreciated' Spero with Buy rating
12/16/20 Berenberg
Spero Therapeutics initiated with a Buy at Berenberg
11/23/20 H.C. Wainwright
Spero Therapeutics price target raised to $33 from $28 at H.C. Wainwright
SLRX Salarius Pharmaceuticals
/

+

ZYNE Zynerba
$4.91 /

+ (+0.00%)

06/25/21 Alliance Global Partners
Cannabis selloff brings buying opportunities, says Alliance Global
05/06/21 Cantor Fitzgerald
Zynerba price target raised to $8 from $6 at Cantor Fitzgerald
03/29/21 Stifel
Stifel says New York adult use cannabis market represents $5B opportunity
03/10/21 Roth Capital
Zynerba price target lowered to $7.25 from $8.00 at Roth Capital
TARA Protara Therapeutics
$8.81 /

-0.23 (-2.54%)

06/04/21 H.C. Wainwright
Protara Therapeutics initiated with a Buy at H.C. Wainwright
04/26/21 Oppenheimer
Protara Therapeutics price target lowered to $32 from $43 at Oppenheimer
10/19/20 Cowen
Protara Therapeutics initiated with an Outperform at Cowen
07/29/20
Fly Intel: Top five analyst initiations
ITMR Itamar Medical
$23.04 /

-0.16 (-0.69%)

06/01/21 Piper Sandler
Itamar Medical shares are undervalued, says Piper Sandler
05/19/21 Piper Sandler
Itamar Medical being conservative with guidance, says Piper Sandler
03/08/21 H.C. Wainwright
Itamar Medical price target raised to $36 from $30 at H.C. Wainwright
03/02/21 Piper Sandler
Itamar Medical price target raised to $30 from $26 at Piper Sandler
CATB Catabasis Pharmaceuticals
$1.82 /

-0.16 (-8.08%)

05/12/21 Ladenburg
Ladenburg starts Catabasis Pharmaceuticals at Buy with $6 price target
05/12/21 Ladenburg
Catabasis Pharmaceuticals initiated with a Buy at Ladenburg
03/11/21 Oppenheimer
Catabasis Pharmaceuticals upgraded to Outperform at Oppenheimer
03/11/21 Oppenheimer
Catabasis upgraded to Outperform from Perform at Oppenheimer
BWAY Brainsway
$9.50 /

-0.15 (-1.55%)

04/20/21 Northland
Brainsway initiated with an Outperform at Northland
02/17/21 Raymond James
Brainsway price target raised to $12 from $9 at Raymond James
BNGO Bionano Genomics
$6.08 /

-0.43 (-6.61%)

06/16/21 BTIG
Bionano Genomics initiated with a Buy at BTIG
02/08/21 Oppenheimer
Bionano Genomics price target raised to $15 from $1.50 at Oppenheimer
01/26/21 Ladenburg
Bionano Genomics price target raised to $14 from $1.25 at Ladenburg
01/22/21 Maxim
Bionano Genomics price target raised to $14 from $2 at Maxim
AXSM Axsome Therapeutics
$63.37 /

-1.92 (-2.94%)

06/10/21
Fly Intel: Top five analyst initiations
06/10/21 Berenberg
Berenberg starts Axsome Therapeutics at Buy ahead of 'transformational year'
06/10/21 Berenberg
Axsome Therapeutics initiated with a Buy at Berenberg
04/27/21 H.C. Wainwright
Axsome Therapeutics price target raised to $225 from $210 at H.C. Wainwright
ARX Aeroflex
$10.50 /

+ (+0.00%)

XCUR Exicure
$1.48 /

-0.015 (-1.00%)

06/11/21 BMO Capital
Exicure coverage transferred at BMO Capital
12/18/20 BMO Capital
Exicure initiated with an Outperform at BMO Capital
ZYNE Zynerba
$4.91 /

+ (+0.00%)

XCUR Exicure
$1.48 /

-0.015 (-1.00%)

VCEL Vericel
$53.57 /

-0.35 (-0.65%)

TARA Protara Therapeutics
$8.81 /

-0.23 (-2.54%)

SPRO Spero Therapeutics
$14.38 /

-0.64 (-4.26%)

PHGE BiomX
$5.75 /

+0.17 (+3.05%)

LBPS 4D pharma
$10.16 /

-0.01 (-0.10%)

ITMR Itamar Medical
$23.04 /

-0.16 (-0.69%)

IMNM Immunome
$16.07 /

-0.85 (-5.02%)

FSTX F-star Therapeutics
$7.25 /

-0.56 (-7.17%)

CATB Catabasis Pharmaceuticals
$1.82 /

-0.16 (-8.08%)

BWAY Brainsway
$9.50 /

-0.15 (-1.55%)

BNGO Bionano Genomics
$6.08 /

-0.43 (-6.61%)

AYLA Ayala Pharmaceuticals
$11.36 /

+0.75 (+7.07%)

AXSM Axsome Therapeutics
$63.37 /

-1.92 (-2.94%)

  • 09
    May
  • 04
    Mar
  • 23
    Feb
  • 05
    Feb
  • 20
    Jan
  • 08
    Jan
  • 02
    Oct
  • 22
    Sep
  • 11
    Sep
  • 05
    Aug
  • 30
    Jul
ZYNE Zynerba
$4.91 /

+ (+0.00%)

ZYNE Zynerba
$4.91 /

+ (+0.00%)

VCEL Vericel
$53.57 /

-0.35 (-0.65%)

SPRO Spero Therapeutics
$14.38 /

-0.64 (-4.26%)

ITMR Itamar Medical
$23.04 /

-0.16 (-0.69%)

IMUX Immunic
$12.31 /

-0.5 (-3.90%)

IMNM Immunome
$16.07 /

-0.85 (-5.02%)

CATB Catabasis Pharmaceuticals
$1.82 /

-0.16 (-8.08%)

BNGO Bionano Genomics
$6.08 /

-0.43 (-6.61%)

ZYNE Zynerba
$4.91 /

+ (+0.00%)

TARA Protara Therapeutics
$8.81 /

-0.23 (-2.54%)

IMNM Immunome
$16.07 /

-0.85 (-5.02%)

FSTX F-star Therapeutics
$7.25 /

-0.56 (-7.17%)

BNGO Bionano Genomics
$6.08 /

-0.43 (-6.61%)

Conference/Events
Ladeburg to hold a virtual conference » 04:55
07/13/21
07/13
04:55
07/13/21
04:55
PHGE

BiomX

$5.61 /

-0.14 (-2.43%)

, AYLA

Ayala Pharmaceuticals

$10.61 /

+1.91 (+21.95%)

, VCEL

Vericel

$53.93 /

+1.01 (+1.91%)

, FSTX

F-star Therapeutics

$7.81 /

-0.29 (-3.58%)

, LBPS

4D pharma

$10.17 /

-0.23 (-2.21%)

, IMUX

Immunic

$12.81 /

+0.27 (+2.15%)

, IMNM

Immunome

$16.92 /

-0.54 (-3.09%)

, SPRO

Spero Therapeutics

$15.02 /

-0.73 (-4.63%)

, SLRX

Salarius Pharmaceuticals

/

+

, ZYNE

Zynerba

$4.91 /

-0.23 (-4.48%)

, TARA

Protara Therapeutics

$9.04 /

+0.02 (+0.22%)

, ITMR

Itamar Medical

$23.04 /

-0.01 (-0.04%)

, CATB

Catabasis Pharmaceuticals

$1.98 /

-0.025 (-1.25%)

, BWAY

Brainsway

$9.65 /

+0.11 (+1.15%)

, BNGO

Bionano Genomics

$6.51 /

-0.25 (-3.70%)

, AXSM

Axsome Therapeutics

$65.29 /

-0.06 (-0.09%)

, ARX

Aeroflex

$10.50 /

+ (+0.00%)

, XCUR

Exicure

$1.50 /

-0.065 (-4.17%)

Healthcare Virtual…

Healthcare Virtual Conference will be held on July 13-14.Webcast Link

ShowHide Related Items >><<
ZYNE Zynerba
$4.91 /

-0.23 (-4.48%)

XCUR Exicure
$1.50 /

-0.065 (-4.17%)

VCEL Vericel
$53.93 /

+1.01 (+1.91%)

TARA Protara Therapeutics
$9.04 /

+0.02 (+0.22%)

SPRO Spero Therapeutics
$15.02 /

-0.73 (-4.63%)

SLRX Salarius Pharmaceuticals
/

+

PHGE BiomX
$5.61 /

-0.14 (-2.43%)

LBPS 4D pharma
$10.17 /

-0.23 (-2.21%)

ITMR Itamar Medical
$23.04 /

-0.01 (-0.04%)

IMUX Immunic
$12.81 /

+0.27 (+2.15%)

IMNM Immunome
$16.92 /

-0.54 (-3.09%)

FSTX F-star Therapeutics
$7.81 /

-0.29 (-3.58%)

CATB Catabasis Pharmaceuticals
$1.98 /

-0.025 (-1.25%)

BWAY Brainsway
$9.65 /

+0.11 (+1.15%)

BNGO Bionano Genomics
$6.51 /

-0.25 (-3.70%)

AYLA Ayala Pharmaceuticals
$10.61 /

+1.91 (+21.95%)

AXSM Axsome Therapeutics
$65.29 /

-0.06 (-0.09%)

PHGE BiomX
$5.61 /

-0.14 (-2.43%)

04/15/21 Ladenburg
Ladenburg starts BiomX with $25 target, says buy ahead of acne data
04/15/21 Ladenburg
BiomX initiated with a Buy at Ladenburg
02/02/21 H.C. Wainwright
BiomX overcame 'significant hurdle' with Phase 1a data, says H.C. Wainwright
12/07/20 H.C. Wainwright
BiomX initiated with a Buy at H.C. Wainwright
AYLA Ayala Pharmaceuticals
$10.61 /

+1.91 (+21.95%)

12/07/20
Fly Intel: Top five analyst initiations
12/07/20 Roth Capital
Ayala Pharmaceuticals initiated with a Buy at Roth Capital
12/02/20
Fly Intel: Top five analyst initiations
12/02/20 Noble Capital
Ayala Pharmaceuticals initiated with an Outperform at Noble Capital
VCEL Vericel
$53.93 /

+1.01 (+1.91%)

05/06/21 H.C. Wainwright
Vericel price target raised to $65 from $60 at H.C. Wainwright
02/25/21 SVB Leerink
Vericel price target raised to $60 from $50 at SVB Leerink
02/22/21 BTIG
Vericel price target raised to $56 from $45 at BTIG
02/16/21 Truist
Vericel price target raised to $60 from $40 at Truist
FSTX F-star Therapeutics
$7.81 /

-0.29 (-3.58%)

07/08/21 SVB Leerink
F-star Therapeutics initiated with an Outperform at SVB Leerink
06/09/21 B. Riley
B. Riley starts F-star Therapeutics at Buy, sees 307% potential upside
06/08/21 B. Riley
F-star Therapeutics initiated with a Buy at B. Riley
04/15/21 Oppenheimer
Opco starts F-star Therapeutics with Outperform, $30 price target
LBPS 4D pharma
$10.17 /

-0.23 (-2.21%)

07/09/21 Chardan
4D pharma assumed with a Buy at Chardan
05/13/21
Fly Intel: Top five analyst initiations
05/13/21 Ladenburg
Ladenburg starts 4D pharma with Buy, $35 price target
05/13/21 Ladenburg
4D pharma initiated with a Buy at Ladenburg
IMUX Immunic
$12.81 /

+0.27 (+2.15%)

07/13/21 Piper Sandler
Investors 'missing out' on Immunic's IMU-935 opportunity, says Piper Sandler
07/02/21 Roth Capital
Immunic cleared for Phase 3 studies after 'stellar' data, says Roth Capital
07/01/21 Piper Sandler
Piper Sandler 'pleased' with Immunic's IMU-838 IND clearance, studies
05/07/21 JMP Securities
Immunic price target raised to $56 from $55 at JMP Securities
IMNM Immunome
$16.92 /

-0.54 (-3.09%)

10/27/20 Chardan
Immunome initiated with a Buy at Chardan
10/26/20 Ladenburg
Immunome initiated with a Buy at Ladenburg
SPRO Spero Therapeutics
$15.02 /

-0.73 (-4.63%)

01/22/21 H.C. Wainwright
Spero Therapeutics price target raised to $40 from $33 at H.C. Wainwright
12/16/20 Berenberg
Berenberg starts 'greatly underappreciated' Spero with Buy rating
12/16/20 Berenberg
Spero Therapeutics initiated with a Buy at Berenberg
11/23/20 H.C. Wainwright
Spero Therapeutics price target raised to $33 from $28 at H.C. Wainwright
SLRX Salarius Pharmaceuticals
/

+

ZYNE Zynerba
$4.91 /

-0.23 (-4.48%)

06/25/21 Alliance Global Partners
Cannabis selloff brings buying opportunities, says Alliance Global
05/06/21 Cantor Fitzgerald
Zynerba price target raised to $8 from $6 at Cantor Fitzgerald
03/29/21 Stifel
Stifel says New York adult use cannabis market represents $5B opportunity
03/10/21 Roth Capital
Zynerba price target lowered to $7.25 from $8.00 at Roth Capital
TARA Protara Therapeutics
$9.04 /

+0.02 (+0.22%)

06/04/21 H.C. Wainwright
Protara Therapeutics initiated with a Buy at H.C. Wainwright
04/26/21 Oppenheimer
Protara Therapeutics price target lowered to $32 from $43 at Oppenheimer
10/19/20 Cowen
Protara Therapeutics initiated with an Outperform at Cowen
07/29/20
Fly Intel: Top five analyst initiations
ITMR Itamar Medical
$23.04 /

-0.01 (-0.04%)

06/01/21 Piper Sandler
Itamar Medical shares are undervalued, says Piper Sandler
05/19/21 Piper Sandler
Itamar Medical being conservative with guidance, says Piper Sandler
03/08/21 H.C. Wainwright
Itamar Medical price target raised to $36 from $30 at H.C. Wainwright
03/02/21 Piper Sandler
Itamar Medical price target raised to $30 from $26 at Piper Sandler
CATB Catabasis Pharmaceuticals
$1.98 /

-0.025 (-1.25%)

05/12/21 Ladenburg
Ladenburg starts Catabasis Pharmaceuticals at Buy with $6 price target
05/12/21 Ladenburg
Catabasis Pharmaceuticals initiated with a Buy at Ladenburg
03/11/21 Oppenheimer
Catabasis Pharmaceuticals upgraded to Outperform at Oppenheimer
03/11/21 Oppenheimer
Catabasis upgraded to Outperform from Perform at Oppenheimer
BWAY Brainsway
$9.65 /

+0.11 (+1.15%)

04/20/21 Northland
Brainsway initiated with an Outperform at Northland
02/17/21 Raymond James
Brainsway price target raised to $12 from $9 at Raymond James
BNGO Bionano Genomics
$6.51 /

-0.25 (-3.70%)

06/16/21 BTIG
Bionano Genomics initiated with a Buy at BTIG
02/08/21 Oppenheimer
Bionano Genomics price target raised to $15 from $1.50 at Oppenheimer
01/26/21 Ladenburg
Bionano Genomics price target raised to $14 from $1.25 at Ladenburg
01/22/21 Maxim
Bionano Genomics price target raised to $14 from $2 at Maxim
AXSM Axsome Therapeutics
$65.29 /

-0.06 (-0.09%)

06/10/21
Fly Intel: Top five analyst initiations
06/10/21 Berenberg
Berenberg starts Axsome Therapeutics at Buy ahead of 'transformational year'
06/10/21 Berenberg
Axsome Therapeutics initiated with a Buy at Berenberg
04/27/21 H.C. Wainwright
Axsome Therapeutics price target raised to $225 from $210 at H.C. Wainwright
ARX Aeroflex
$10.50 /

+ (+0.00%)

XCUR Exicure
$1.50 /

-0.065 (-4.17%)

06/11/21 BMO Capital
Exicure coverage transferred at BMO Capital
12/18/20 BMO Capital
Exicure initiated with an Outperform at BMO Capital
ZYNE Zynerba
$4.91 /

-0.23 (-4.48%)

XCUR Exicure
$1.50 /

-0.065 (-4.17%)

VCEL Vericel
$53.93 /

+1.01 (+1.91%)

TARA Protara Therapeutics
$9.04 /

+0.02 (+0.22%)

SPRO Spero Therapeutics
$15.02 /

-0.73 (-4.63%)

PHGE BiomX
$5.61 /

-0.14 (-2.43%)

LBPS 4D pharma
$10.17 /

-0.23 (-2.21%)

ITMR Itamar Medical
$23.04 /

-0.01 (-0.04%)

IMNM Immunome
$16.92 /

-0.54 (-3.09%)

FSTX F-star Therapeutics
$7.81 /

-0.29 (-3.58%)

CATB Catabasis Pharmaceuticals
$1.98 /

-0.025 (-1.25%)

BWAY Brainsway
$9.65 /

+0.11 (+1.15%)

BNGO Bionano Genomics
$6.51 /

-0.25 (-3.70%)

AYLA Ayala Pharmaceuticals
$10.61 /

+1.91 (+21.95%)

AXSM Axsome Therapeutics
$65.29 /

-0.06 (-0.09%)

  • 09
    May
  • 04
    Mar
  • 23
    Feb
  • 05
    Feb
  • 20
    Jan
  • 08
    Jan
  • 02
    Oct
  • 22
    Sep
  • 11
    Sep
  • 05
    Aug
  • 30
    Jul
ZYNE Zynerba
$4.91 /

-0.23 (-4.48%)

ZYNE Zynerba
$4.91 /

-0.23 (-4.48%)

VCEL Vericel
$53.93 /

+1.01 (+1.91%)

SPRO Spero Therapeutics
$15.02 /

-0.73 (-4.63%)

ITMR Itamar Medical
$23.04 /

-0.01 (-0.04%)

IMUX Immunic
$12.81 /

+0.27 (+2.15%)

IMNM Immunome
$16.92 /

-0.54 (-3.09%)

CATB Catabasis Pharmaceuticals
$1.98 /

-0.025 (-1.25%)

BNGO Bionano Genomics
$6.51 /

-0.25 (-3.70%)

ZYNE Zynerba
$4.91 /

-0.23 (-4.48%)

TARA Protara Therapeutics
$9.04 /

+0.02 (+0.22%)

IMNM Immunome
$16.92 /

-0.54 (-3.09%)

FSTX F-star Therapeutics
$7.81 /

-0.29 (-3.58%)

BNGO Bionano Genomics
$6.51 /

-0.25 (-3.70%)

Conference/Events
Ladeburg to hold a virtual conference » 16:50
07/12/21
07/12
16:50
07/12/21
16:50
PHGE

BiomX

$5.61 /

-0.14 (-2.43%)

, AYLA

Ayala Pharmaceuticals

$10.61 /

+1.91 (+21.95%)

, VCEL

Vericel

$53.93 /

+1.01 (+1.91%)

, FSTX

F-star Therapeutics

$7.81 /

-0.29 (-3.58%)

, LBPS

4D pharma

$10.17 /

-0.23 (-2.21%)

, IMUX

Immunic

$12.81 /

+0.27 (+2.15%)

, IMNM

Immunome

$16.92 /

-0.54 (-3.09%)

, SPRO

Spero Therapeutics

$15.02 /

-0.73 (-4.63%)

, SLRX

Salarius Pharmaceuticals

/

+

, ZYNE

Zynerba

$4.91 /

-0.23 (-4.48%)

, TARA

Protara Therapeutics

$9.04 /

+0.02 (+0.22%)

, ITMR

Itamar Medical

$23.04 /

-0.01 (-0.04%)

, CATB

Catabasis Pharmaceuticals

$1.98 /

-0.025 (-1.25%)

, BWAY

Brainsway

$9.65 /

+0.11 (+1.15%)

, BNGO

Bionano Genomics

$6.51 /

-0.25 (-3.70%)

, AXSM

Axsome Therapeutics

$65.29 /

-0.06 (-0.09%)

, ARX

Aeroflex

$10.50 /

+ (+0.00%)

, XCUR

Exicure

$1.50 /

-0.065 (-4.17%)

Healthcare Virtual…

Healthcare Virtual Conference will be held on July 13-14.Webcast Link

ShowHide Related Items >><<
ZYNE Zynerba
$4.91 /

-0.23 (-4.48%)

XCUR Exicure
$1.50 /

-0.065 (-4.17%)

VCEL Vericel
$53.93 /

+1.01 (+1.91%)

TARA Protara Therapeutics
$9.04 /

+0.02 (+0.22%)

SPRO Spero Therapeutics
$15.02 /

-0.73 (-4.63%)

SLRX Salarius Pharmaceuticals
/

+

PHGE BiomX
$5.61 /

-0.14 (-2.43%)

LBPS 4D pharma
$10.17 /

-0.23 (-2.21%)

ITMR Itamar Medical
$23.04 /

-0.01 (-0.04%)

IMUX Immunic
$12.81 /

+0.27 (+2.15%)

IMNM Immunome
$16.92 /

-0.54 (-3.09%)

FSTX F-star Therapeutics
$7.81 /

-0.29 (-3.58%)

CATB Catabasis Pharmaceuticals
$1.98 /

-0.025 (-1.25%)

BWAY Brainsway
$9.65 /

+0.11 (+1.15%)

BNGO Bionano Genomics
$6.51 /

-0.25 (-3.70%)

AYLA Ayala Pharmaceuticals
$10.61 /

+1.91 (+21.95%)

AXSM Axsome Therapeutics
$65.29 /

-0.06 (-0.09%)

PHGE BiomX
$5.61 /

-0.14 (-2.43%)

04/15/21 Ladenburg
Ladenburg starts BiomX with $25 target, says buy ahead of acne data
04/15/21 Ladenburg
BiomX initiated with a Buy at Ladenburg
02/02/21 H.C. Wainwright
BiomX overcame 'significant hurdle' with Phase 1a data, says H.C. Wainwright
12/07/20 H.C. Wainwright
BiomX initiated with a Buy at H.C. Wainwright
AYLA Ayala Pharmaceuticals
$10.61 /

+1.91 (+21.95%)

12/07/20
Fly Intel: Top five analyst initiations
12/07/20 Roth Capital
Ayala Pharmaceuticals initiated with a Buy at Roth Capital
12/02/20
Fly Intel: Top five analyst initiations
12/02/20 Noble Capital
Ayala Pharmaceuticals initiated with an Outperform at Noble Capital
VCEL Vericel
$53.93 /

+1.01 (+1.91%)

05/06/21 H.C. Wainwright
Vericel price target raised to $65 from $60 at H.C. Wainwright
02/25/21 SVB Leerink
Vericel price target raised to $60 from $50 at SVB Leerink
02/22/21 BTIG
Vericel price target raised to $56 from $45 at BTIG
02/16/21 Truist
Vericel price target raised to $60 from $40 at Truist
FSTX F-star Therapeutics
$7.81 /

-0.29 (-3.58%)

07/08/21 SVB Leerink
F-star Therapeutics initiated with an Outperform at SVB Leerink
06/09/21 B. Riley
B. Riley starts F-star Therapeutics at Buy, sees 307% potential upside
06/08/21 B. Riley
F-star Therapeutics initiated with a Buy at B. Riley
04/15/21 Oppenheimer
Opco starts F-star Therapeutics with Outperform, $30 price target
LBPS 4D pharma
$10.17 /

-0.23 (-2.21%)

07/09/21 Chardan
4D pharma assumed with a Buy at Chardan
05/13/21
Fly Intel: Top five analyst initiations
05/13/21 Ladenburg
Ladenburg starts 4D pharma with Buy, $35 price target
05/13/21 Ladenburg
4D pharma initiated with a Buy at Ladenburg
IMUX Immunic
$12.81 /

+0.27 (+2.15%)

07/02/21 Roth Capital
Immunic cleared for Phase 3 studies after 'stellar' data, says Roth Capital
07/01/21 Piper Sandler
Piper Sandler 'pleased' with Immunic's IMU-838 IND clearance, studies
05/07/21 JMP Securities
Immunic price target raised to $56 from $55 at JMP Securities
04/15/21 Piper Sandler
Piper Sandler 'very encouraged' by Immunic Phase 2 EMPhASIS cohort 2 data
IMNM Immunome
$16.92 /

-0.54 (-3.09%)

10/27/20 Chardan
Immunome initiated with a Buy at Chardan
10/26/20 Ladenburg
Immunome initiated with a Buy at Ladenburg
SPRO Spero Therapeutics
$15.02 /

-0.73 (-4.63%)

01/22/21 H.C. Wainwright
Spero Therapeutics price target raised to $40 from $33 at H.C. Wainwright
12/16/20 Berenberg
Berenberg starts 'greatly underappreciated' Spero with Buy rating
12/16/20 Berenberg
Spero Therapeutics initiated with a Buy at Berenberg
11/23/20 H.C. Wainwright
Spero Therapeutics price target raised to $33 from $28 at H.C. Wainwright
SLRX Salarius Pharmaceuticals
/

+

ZYNE Zynerba
$4.91 /

-0.23 (-4.48%)

06/25/21 Alliance Global Partners
Cannabis selloff brings buying opportunities, says Alliance Global
05/06/21 Cantor Fitzgerald
Zynerba price target raised to $8 from $6 at Cantor Fitzgerald
03/29/21 Stifel
Stifel says New York adult use cannabis market represents $5B opportunity
03/10/21 Roth Capital
Zynerba price target lowered to $7.25 from $8.00 at Roth Capital
TARA Protara Therapeutics
$9.04 /

+0.02 (+0.22%)

06/04/21 H.C. Wainwright
Protara Therapeutics initiated with a Buy at H.C. Wainwright
04/26/21 Oppenheimer
Protara Therapeutics price target lowered to $32 from $43 at Oppenheimer
10/19/20 Cowen
Protara Therapeutics initiated with an Outperform at Cowen
07/29/20
Fly Intel: Top five analyst initiations
ITMR Itamar Medical
$23.04 /

-0.01 (-0.04%)

06/01/21 Piper Sandler
Itamar Medical shares are undervalued, says Piper Sandler
05/19/21 Piper Sandler
Itamar Medical being conservative with guidance, says Piper Sandler
03/08/21 H.C. Wainwright
Itamar Medical price target raised to $36 from $30 at H.C. Wainwright
03/02/21 Piper Sandler
Itamar Medical price target raised to $30 from $26 at Piper Sandler
CATB Catabasis Pharmaceuticals
$1.98 /

-0.025 (-1.25%)

05/12/21 Ladenburg
Ladenburg starts Catabasis Pharmaceuticals at Buy with $6 price target
05/12/21 Ladenburg
Catabasis Pharmaceuticals initiated with a Buy at Ladenburg
03/11/21 Oppenheimer
Catabasis Pharmaceuticals upgraded to Outperform at Oppenheimer
03/11/21 Oppenheimer
Catabasis upgraded to Outperform from Perform at Oppenheimer
BWAY Brainsway
$9.65 /

+0.11 (+1.15%)

04/20/21 Northland
Brainsway initiated with an Outperform at Northland
02/17/21 Raymond James
Brainsway price target raised to $12 from $9 at Raymond James
BNGO Bionano Genomics
$6.51 /

-0.25 (-3.70%)

06/16/21 BTIG
Bionano Genomics initiated with a Buy at BTIG
02/08/21 Oppenheimer
Bionano Genomics price target raised to $15 from $1.50 at Oppenheimer
01/26/21 Ladenburg
Bionano Genomics price target raised to $14 from $1.25 at Ladenburg
01/22/21 Maxim
Bionano Genomics price target raised to $14 from $2 at Maxim
AXSM Axsome Therapeutics
$65.29 /

-0.06 (-0.09%)

06/10/21
Fly Intel: Top five analyst initiations
06/10/21 Berenberg
Berenberg starts Axsome Therapeutics at Buy ahead of 'transformational year'
06/10/21 Berenberg
Axsome Therapeutics initiated with a Buy at Berenberg
04/27/21 H.C. Wainwright
Axsome Therapeutics price target raised to $225 from $210 at H.C. Wainwright
ARX Aeroflex
$10.50 /

+ (+0.00%)

XCUR Exicure
$1.50 /

-0.065 (-4.17%)

06/11/21 BMO Capital
Exicure coverage transferred at BMO Capital
12/18/20 BMO Capital
Exicure initiated with an Outperform at BMO Capital
ZYNE Zynerba
$4.91 /

-0.23 (-4.48%)

XCUR Exicure
$1.50 /

-0.065 (-4.17%)

VCEL Vericel
$53.93 /

+1.01 (+1.91%)

TARA Protara Therapeutics
$9.04 /

+0.02 (+0.22%)

SPRO Spero Therapeutics
$15.02 /

-0.73 (-4.63%)

PHGE BiomX
$5.61 /

-0.14 (-2.43%)

LBPS 4D pharma
$10.17 /

-0.23 (-2.21%)

ITMR Itamar Medical
$23.04 /

-0.01 (-0.04%)

IMNM Immunome
$16.92 /

-0.54 (-3.09%)

FSTX F-star Therapeutics
$7.81 /

-0.29 (-3.58%)

CATB Catabasis Pharmaceuticals
$1.98 /

-0.025 (-1.25%)

BWAY Brainsway
$9.65 /

+0.11 (+1.15%)

BNGO Bionano Genomics
$6.51 /

-0.25 (-3.70%)

AYLA Ayala Pharmaceuticals
$10.61 /

+1.91 (+21.95%)

AXSM Axsome Therapeutics
$65.29 /

-0.06 (-0.09%)

  • 09
    May
  • 04
    Mar
  • 23
    Feb
  • 05
    Feb
  • 20
    Jan
  • 08
    Jan
  • 02
    Oct
  • 22
    Sep
  • 11
    Sep
  • 05
    Aug
  • 30
    Jul
ZYNE Zynerba
$4.91 /

-0.23 (-4.48%)

ZYNE Zynerba
$4.91 /

-0.23 (-4.48%)

VCEL Vericel
$53.93 /

+1.01 (+1.91%)

SPRO Spero Therapeutics
$15.02 /

-0.73 (-4.63%)

ITMR Itamar Medical
$23.04 /

-0.01 (-0.04%)

IMUX Immunic
$12.81 /

+0.27 (+2.15%)

IMNM Immunome
$16.92 /

-0.54 (-3.09%)

CATB Catabasis Pharmaceuticals
$1.98 /

-0.025 (-1.25%)

BNGO Bionano Genomics
$6.51 /

-0.25 (-3.70%)

ZYNE Zynerba
$4.91 /

-0.23 (-4.48%)

TARA Protara Therapeutics
$9.04 /

+0.02 (+0.22%)

IMNM Immunome
$16.92 /

-0.54 (-3.09%)

FSTX F-star Therapeutics
$7.81 /

-0.29 (-3.58%)

BNGO Bionano Genomics
$6.51 /

-0.25 (-3.70%)

Initiation
4D pharma assumed with a Buy at Chardan » 16:26
07/09/21
07/09
16:26
07/09/21
16:26
LBPS

4D pharma

$10.40 /

-0.26 (-2.44%)

Chardan analyst Keay…

Chardan analyst Keay Nakae assumed coverage of 4D pharma with a Buy rating and $40 price target. The firm's prior ratings and price targets remain unchanged.

ShowHide Related Items >><<
LBPS 4D pharma
$10.40 /

-0.26 (-2.44%)

LBPS 4D pharma
$10.40 /

-0.26 (-2.44%)

05/13/21
Fly Intel: Top five analyst initiations
05/13/21 Ladenburg
Ladenburg starts 4D pharma with Buy, $35 price target
05/13/21 Ladenburg
4D pharma initiated with a Buy at Ladenburg
04/19/21 Chardan
4D pharma named a 'Top Pick for 2021' for at Chardan
LBPS 4D pharma
$10.40 /

-0.26 (-2.44%)

Hot Stocks
4D pharma publishes research showing LBP MRx1299 improving the activity of CAR-T » 07:11
07/06/21
07/06
07:11
07/06/21
07:11
LBPS

4D pharma

$10.65 /

-0.16 (-1.48%)

4D pharma announces the…

4D pharma announces the publication of pre-clinical research relating to its second-generation immuno-oncology LBP MRx1299 improving the activity of CAR-T. The research, conducted in collaboration with the Philipps-University Marburg, Germany, and Universitatsklinikum Wurzburg, Germany, and published in Nature Communications, demonstrates the ability of the bacterium Megasphaera massiliensis or its short chain fatty acid metabolite pentanoate to enhance the anti-tumor activity of cytotoxic T lymphocytes and CAR-T therapies in animal models of cancer, resulting in better tumor clearance. "Our existing clinical oncology programs, such as the study of MRx0518 and Keytruda in refractory patients, have shown the important role our live biotherapeutics have to play in the fight against cancer in combination with immunotherapies. Using the MicroRx platform we have now shown we have the potential to improve the efficacies of cell therapies such as CAR-T," commented Dr. Imke Mulder, Research Director, 4D pharma. "This demonstrates not only the importance of Live Biotherapeutics as a new modality poised to revolutionize the treatment of a wide range of cancers, but also the power of our MicroRx platform to continue making significant discoveries and advances in this field."

ShowHide Related Items >><<
LBPS 4D pharma
$10.65 /

-0.16 (-1.48%)

LBPS 4D pharma
$10.65 /

-0.16 (-1.48%)

05/13/21
Fly Intel: Top five analyst initiations
05/13/21 Ladenburg
Ladenburg starts 4D pharma with Buy, $35 price target
05/13/21 Ladenburg
4D pharma initiated with a Buy at Ladenburg
04/19/21 Chardan
4D pharma named a 'Top Pick for 2021' for at Chardan
LBPS 4D pharma
$10.65 /

-0.16 (-1.48%)

Over a quarter ago
Hot Stocks
4D pharma completes enrollment in one study, discontinues enrollment in another » 07:07
06/04/21
06/04
07:07
06/04/21
07:07
LBPS

4D pharma

$10.73 /

+0.65 (+6.45%)

4D pharma announced the…

4D pharma announced the completion of its target enrollment of 30 patients for Part A of its Phase I/II clinical trial of MRx-4DP0004 in patients with partly-controlled asthma. Following the completion of enrollment of Part A, 4D pharma expects to announce topline results from these patients in the second half of 2021. 4D pharma also announces the voluntary discontinuation of enrollment in the Phase II study of MRx-4DP0004 for the treatment of hospitalized patients with COVID-19 in the UK, in order to focus on its core LBP pipeline candidates due to the increase in vaccination rates, declining hospitalization rates, and progress in the MRx-4DP0004 asthma clinical trial.

ShowHide Related Items >><<
LBPS 4D pharma
$10.73 /

+0.65 (+6.45%)

LBPS 4D pharma
$10.73 /

+0.65 (+6.45%)

05/13/21
Fly Intel: Top five analyst initiations
05/13/21 Ladenburg
Ladenburg starts 4D pharma with Buy, $35 price target
05/13/21 Ladenburg
4D pharma initiated with a Buy at Ladenburg
04/19/21 Chardan
4D pharma named a 'Top Pick for 2021' for at Chardan
LBPS 4D pharma
$10.73 /

+0.65 (+6.45%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.